Tan Lab | DSigDB

Gene Set: D4 : CTD - tesaglitazar

Collection

D4 : CTD

Chemical Name

tesaglitazar ( From PubChem : TESAGLITAZAR )

FDA	NPC	WHO	Indian	Australia	China	Traditional Herbal	Clinical Trail
Not	Approved	Not	Not	Not	Not	Not	Not

Molecular Weight	Hydrogen Bond Donor Count	Hydrogen Bond Acceptor Count	cLogP	Lipinski Rule
408.465 g/mol	1	7	3.7595	True

Structure

InChI

InChI=1S/C20H24O7S/c1-3-25-19(20(21)22)14-16-6-8-17(9-7-16)26-13-12-15-4-10-18(11-5-15)27-28(2,23)24/h4-11,19H,3,12-14H2,1-2H3,(H,21,22)/t19-/m0/s1

InChIKey

Links

Gene (14 / 31)

⊖ Less

Source	Type	Gene	Other
CTD	affects(cotreatment)	ACOX1	C501413
CTD	increases(expression)	ACOX1	C501413
CTD	affects(cotreatment)	ALB	C501413
CTD	increases(expression)	ALB	C501413
CTD	affects(cotreatment)	APOC3	C501413
CTD	increases(expression)	APOC3	C501413
CTD	increases(expression)	CPT1A	C501413
CTD	increases(reaction)	CPT1A	C501413
CTD	affects(cotreatment)	CPT2	C501413
CTD	increases(expression)	CPT2	C501413
CTD	affects(cotreatment)	ECH1	C501413
CTD	increases(expression)	ECH1	C501413
CTD	affects(cotreatment)	ELOVL6	C501413
CTD	increases(expression)	ELOVL6	C501413
CTD	increases(activity)	FABP1	C501413
CTD	increases(expression)	FABP1	C501413
CTD	affects(cotreatment)	NR1H3	C501413
CTD	affects(expression)	NR1H3	C501413
CTD	increases(expression)	PLIN2	C501413
CTD	increases(reaction)	PLIN2	C501413
CTD	increases(expression)	PLIN4	C501413
CTD	increases(reaction)	PLIN4	C501413
CTD	affects(binding)	PPARA	C501413
CTD	increases(activity)	PPARA	C501413
CTD	increases(activity)	PPARA	C501413
CTD	increases(expression)	PPARA	C501413
CTD	affects(binding)	PPARG	C501413
CTD	increases(activity)	PPARG	C501413
CTD	increases(activity)	PPARG	C501413
CTD	affects(cotreatment)	SCD	C501413
CTD	increases(expression)	SCD	C501413

Download gene sets